Article Details
Retrieved on: 2023-11-21 08:29:41
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Renaissance Technologies LLC now owns 1,186,986 shares of the biopharmaceutical company's stock valued at $626,000 after buying an additional 85,716 ...
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here